Details for Patent: 4,833,790
Summary for Patent: 4,833,790
| Title: | Method and system for locating and positioning circular workpieces | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract: | A system for locating and positioning wafers includes a wafer shuttle, a spindle, and a position sensor. The wafer shuttle retrieves wafers from a storage location, typically a wafer cassette, and transports the wafers to the spindle. The wafers are then incrementally rotated on the spindle, and the distance between the center of rotation and the periphery of the wafer along a linear path is measured. By using three such measurements, the distance and angle with which the center of the wafer is offset from the center of rotation may be calculated. The wafer can then be centered on the spindle by rotation and translated a proper distance by the wafer shuttle. Usually, the wafers will be further rotationally oriented so that the crystal lattice lies in a desired direction. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventor(s): | Robert M. Spencer, Christopher O. Lada | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assignee: | Lam Research Corp | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Application Number: | US07/048,194 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Patent Claim Types: see list of patent claims | Use; | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Patent landscape, scope, and claims: | US Patent 4,833,790: Scope, Claims, Expiration, and Semiconductor Wafer-Positioning Patent LandscapeUS Patent 4,833,790 is not a drug patent. It covers an automated system and method for centering, aligning, and rotationally positioning circular semiconductor workpieces, including silicon wafers. The core invention measures the distance from a fixed rotation center to the wafer edge at multiple rotational positions, calculates the wafer’s lateral offset and angular deviation, and corrects the position through rotation and translation. The patent issued on May 23, 1989. Under the pre-1995 U.S. patent-term regime, its enforceable term would have expired approximately 17 years after issuance, on May 23, 2006, absent an unusual terminal-disclaimer or other exceptional prosecution history. The patent therefore has no current U.S. exclusionary value. What technology does US Patent 4,833,790 protect?The patent protects wafer-handling equipment that performs three related functions:
The system then aligns the wafer by applying:
The claims are directed primarily to semiconductor-wafer handling, although the claim language uses the broader term “circular workpiece.” Potentially covered workpieces could include disks, substrates, optical components, magnetic media, or other circular parts if the claimed structure and operating sequence were present. The central technical concept is geometric centering. If a wafer is mounted off-center on a spindle, the measured radius from the spindle center to the wafer edge varies as the wafer rotates. At least three measurements allow the control system to determine the magnitude and direction of the offset. What are the independent claims in US 4,833,790?The patent has five principal independent claim groups: claims 1, 3, 7, 13, and 17.
Claims 2, 4-6, 8-12, and 14-16 depend on the system claims. Claims 18-21 depend on the method claim or its algorithmic limitations. How broad is claim 1?Claim 1 is the broadest functional system claim in the set. It requires:
The claim does not require:
That breadth is narrowed by the required combination. A system that merely detects the wafer edge, rotates a wafer, or centers a wafer through a vision system would not necessarily meet claim 1. The accused system must use the claimed relationship between a fixed rotation center, multiple angular measurements, and calculated offset. Claim 1 is likely vulnerable to design-arounds that use:
What additional structure does claim 3 require?Claim 3 narrows the invention to a wafer-handling architecture involving:
Dependent claims add specific mechanical details:
These limitations describe a practical semiconductor wafer-transfer machine rather than a generalized centering algorithm. An accused system would need to satisfy the cassette, arm, spindle, and transfer-path limitations for literal infringement of claim 3. The J-shaped arm limitation in claim 6 is particularly narrow. A straight blade, end effector, or robotic arm with a different geometry may avoid literal infringement, although the doctrine of equivalents could become relevant in a live dispute. What does claim 7 cover?Claim 7 focuses on a spindle-based positioning arrangement. It requires:
Claims 8-12 narrow the claim as follows:
Claim 7 is structurally broader than claim 3 because it does not require a cassette, reciprocating transfer arm, or J-shaped arm. It is narrower than claim 1 in other respects because it expressly requires a spindle with selective elevation and rotation. What does claim 13 add through the position sensor?Claim 13 requires a conveyor, a raising and rotating mechanism, and a position sensor that reciprocates along at least part of the linear path. The sensor measures the distance between the rotation center and the wafer periphery. Claims 14-16 specify:
This claim group is important because it distinguishes the sensing architecture from the spindle and wafer-transfer structures in claims 3 and 7. A system could potentially fall within claim 13 even if it used a different wafer-transfer arrangement, provided it used a reciprocating position sensor to make the required distance measurements. The use of “means for reciprocating” and “means for determining” may invoke 35 U.S.C. § 112(f), formerly § 112, paragraph 6. If so, the scope may be limited to the corresponding structures disclosed in the specification and their statutory equivalents, rather than every technology capable of performing the stated function. What method does claim 17 protect?Claim 17 covers the operating sequence rather than a particular machine architecture. It requires:
This is the patent’s most important algorithmic claim. It may read on equipment made by different manufacturers if the equipment performs the same measurement and correction sequence. Claim 18 adds a post-centering operation:
This limitation could apply to wafers with flats, notches, orientation marks, or other peripheral discontinuities. Claim 19 requires repeated measurement to confirm the calculated angular and linear corrections. Claims 20 and 21 add algorithmic limitations for calculating alpha and l from the measured distances. The text supplied for claim 21 does not reproduce the equation, but the claim clearly narrows claim 20 by specifying the mathematical determination of the offset length. How would infringement of US 4,833,790 be analyzed?A literal infringement analysis would normally proceed element by element.
The strongest infringement risk would arise from a wafer aligner that rotates a wafer on a spindle, measures edge position at multiple angles with a linear optical sensor, calculates eccentricity, and translates the wafer to center it. The weakest risk would arise from a modern vision-based aligner that captures a two-dimensional wafer image and calculates the wafer center without measuring radial distance from a fixed rotation center at multiple angular positions. When did US Patent 4,833,790 expire?US Patent 4,833,790 issued May 23, 1989. Patents based on applications filed before June 8, 1995 generally received a term of 17 years from grant under the pre-Uruguay Round Agreements Act framework. The resulting expiration date is approximately May 23, 2006.[1][2]
The patent cannot support a present-day U.S. infringement action unless an unusual legal record altered the ordinary term calculation. Patent expiration eliminates the exclusionary right, although the patent remains relevant as prior art and as evidence of historical technology. What is the Orange Book status of US Patent 4,833,790?There is no Orange Book status. The patent does not claim a pharmaceutical active ingredient, formulation, dosage form, method of treatment, or drug-delivery system. It is directed to industrial automation and semiconductor wafer positioning. The patent therefore has:
FDA approval, Hatch-Waxman litigation, biosimilar competition, and drug patent-term extension concepts do not apply to this patent.[3] What companies and technologies compete in this patent landscape?The relevant commercial landscape is semiconductor wafer handling and alignment equipment. Major technology categories include: Wafer aligners and pre-alignersThese systems center and orient wafers before processing. They may use:
Semiconductor equipment suppliersCompanies active in adjacent wafer-handling and automation markets have included Applied Materials, Tokyo Electron, KLA, Brooks Automation, Genmark Automation, Rorze, and Asyst Technologies. Their current products and patent portfolios must be assessed by product generation and jurisdiction. Company participation in the market does not establish infringement of US 4,833,790. Modern design-around approachesLater systems commonly reduce exposure to this patent’s claim language by using:
The patent’s expired status means the commercial question is no longer freedom to operate under this specific patent. The relevant issue is whether later patents cover the particular sensor, robot, chuck, inspection, or alignment implementation. How strong was the patent estate?The patent appears to have had meaningful historical coverage because it used several independent claim formats:
That diversification reduced dependence on a single machine configuration. The claims also covered both hardware and operating steps, which could have complicated design-around efforts during the patent term. Its limitations were equally important:
The estate is now legally weak for commercial purposes because it is expired. It retains technical and prior-art value, but no current U.S. licensing leverage or litigation leverage. What licensing and litigation risks exist today?No current licensing obligation or active litigation right arises solely from US Patent 4,833,790 because the patent expired in 2006. Any historical license, settlement, covenant not to sue, or assignment could remain relevant to contract interpretation, but the patent itself cannot impose a continuing patent royalty obligation after expiration without a separate enforceable contractual basis. No current Paragraph IV challenge, generic launch dispute, biosimilar dispute, or FDA patent-listing dispute is associated with this patent. The practical litigation risk has shifted to:
What geographic coverage does the patent have?US Patent 4,833,790 provides rights only in the United States. A U.S. patent does not automatically cover:
Foreign counterparts would require a separate family review. The supplied claim set establishes the U.S. claim scope but does not establish corresponding rights in Europe, Japan, Taiwan, South Korea, or other jurisdictions. Key Takeaways
FAQsIs US Patent 4,833,790 a semiconductor wafer patent?Yes. Although the claims say “circular workpiece,” the cassette, wafer-transfer arm, spindle, vacuum port, and rotational alignment features identify semiconductor wafer-handling equipment as the principal application. Can an expired patent still block a wafer-aligner product?No. An expired patent cannot support an infringement claim based on conduct occurring after expiration. It can remain relevant as prior art against later patent applications. Does a camera-based wafer aligner infringe claim 17?Not necessarily. Claim 17 requires measuring the distance between the rotation center and the workpiece periphery at at least three angular positions. A camera system that directly calculates wafer-center coordinates may avoid that limitation, subject to the actual implementation and equivalents analysis. Does the patent cover wafer-notch detection?Claim 18 covers rotational positioning after centering to align discontinuities in the circular periphery. This can include a wafer notch or flat if the claimed centering and subsequent alignment sequence is performed. Is there a current royalty obligation under US Patent 4,833,790?Not from the patent alone. Any continuing obligation would have to arise from a separate contract, license, settlement, or other enforceable agreement. References
More… ↓ |
Drugs Protected by US Patent 4,833,790
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
